Gastroenterology

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains

Source link




Related posts

Motus GI reports net revenue decrease in third quarter, clinical trial enrollment

Newsemia

Global Variation in Personal Health Care Access and Quality

Newsemia

Phase 3 trial of pegilodecakin for metastatic pancreatic cancer fails to meet primary endpoint

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy